FORUM 044 VULVAR DISEASE: WHAT DO YOU KNOW? AN OVERVIEW
|
|
- Ruby Hensley
- 5 years ago
- Views:
Transcription
1 FORUM 044 VULVAR DISEASE: WHAT DO YOU KNOW? AN OVERVIEW Vulvar Neoplasms: Benign and Malignant Jill Allbritton, MD March 2, 2019
2 NO DISCLOSURES WITH INDUSTRY Jill Allbritton, MD Forum 044 Vulvar Disease: What Do You Know? An Overview VULVAR NEOPLASMS: Benign and Malignant DISCLOSURES NONE
3 VULVAR PIGMENTED LESIONS Whats important? 10% of all pigmented lesions occur on genital skin Vulvar melanoma-late diagnosis-less than 50% 5 yr survival Avg depth 4.0 mm 2% of melanomas in women arise on vulva Genital melanoma Females>Males, Greatest in caucasians Only 4% of dermatologists include vulvar exam on FSE stirrups vs supine with feet on corners of table Seehusen DA et al. Improving women s experience during speculum examinations at routine gynecological visits: randomised clinical trial. BMJ 2006;333:171. Zikry J et al. Genital melanoma: are we adequately screening our patients? Dermatol Online J. 2017;23:1-2.
4 MELANOMA Average age % arise in preexisting nevi Most common labia minora, clitoris 5 year survival less than 50% (due to depth at detection) Often multifocal, unlike other sites 25% amelanotic German study - anogenital melanoma deeper Breslow depth than female genital tract Remember perianal area! Heppt et al. Prognostic factors and treatment outcomes in 444 patients with mucosal melanoma. Eur J Cancer 2017:81:36-44.
5 GENITAL MELANOMAS Biopsy new or non resolving erythematous plaques as 25% of genital melanoma unpigmented multifocal sampling for large lesions
6 VULVAR MELANOMA Most common histology -acral lentiginous, then nodular BrafV600E mutations common in dysplastic nevi and common nevi of genital track (>90%) but not of vulvar melanomas Suggests that dysplastic nevi and common nevi are not melanoma precursor in genital tract C-Kit 28% (imatinib)(most common vulvar) NRAS 28% (most common vaginal) Recent study 9/13 vulvar melanomas as PD-L1 expression(nivolumab, pembrolizumab) Swedish study found decrease in rate (3% per yr over last 25yrs) of vulvar melanoma contrasted to increase in rate (6% per year) of cutaneous melanoma International Journal of Gynecological Pathology 37: , Lippincott Williams & Wilkins, Baltimore Copyright 2017 by the International Society of Gynecological Pathologists Gadducci et al. Gynecologic Oncology 150 (2018)
7 AMELANOTIC MELANOMA
8 ATYPICAL NEVI OF GENITAL TYPE AND MIS
9 NODULAR MELANONA
10 VULVAR MELANOSIS Women in 40s rather than 70s Flat, asymmetric, tan to blue, black, irregular borders and size Most common on Labia minora Mucous membranes and modified mucous membranes rather than keratinized skin of vulva Indistinguishable from melanoma clinically Maybe post inflammatory Lichen sclerosus may be predisposing disease Unusual in older women (Suspect Melanoma) No increased risk of melanoma
11
12
13 MANAGEMENT OF VULVAR MELANOSIS Initial photographs Reassured if pt has lichen sclerosus Biopsy Follow up for clinical change Low threshold for biopsy for any clinical change as morphology not distinct in genital pigmented lesions Melanosis NOT premalignant
14 VULVAR SQUAMOUS CELL CARCINOMA Two common distinct pathways 1. Human Papilloma Virus (HPV) related young women often multifocal smokers 20% burden of invasive SCC better prognosis 2. Non HPV related elderly women often associated with lichen sclerosus 80% burden of invasive SCC
15 SQUAMOUS CELL CARCINOMAS HPV RELATED PRECURSORS/NONPRECURSORS A. Human Papilloma Virus (HPV) related 1. Low Grade Squamous Intraepithelial Lesion (LSIL) - (VIN1) 2. High Grade Squamous Intraepithelial Lesion (HSIL)-(VIN2/3) HSIL, VIN often thought to have low rate of progression to SCC 3%, this is in treated patients 10% risk of progression to SCC in untreated patients
16 LOW GRADE SQUAMOUS INTRAEPITHELIAL LESION (LSIL) - (VIN1) HIGH GRADE SQUAMOUS INTRAEPITHELIAL LESION (HSIL)-(VIN2/3) LSIL- condyloma effect HSIL
17 VULVAR HSIL (HIGH GRADE SQUAMOUS INTRAEPITHELIAL LESION- HPV RELATED) % of HSIL progresses to SCC 1% regresses without treatment (usually within 10 months) Regression associated with young age, pregnancy, the presence of multiple pigmented lesions ISSVD refrains from using Bowenoid papulosis as it is impossible to know histologically if lesion will progress or regress
18 High risk HPV types,16 most frequent Stain with p16, Ki67(mitotic index), absence of p53 VULVAR HSIL (VIN)
19 VULVAR HSIL (VIN 3)
20 PERIANAL HSIL (PIN)
21 TREATMENT OF HSIL (USUAL TYPE VIN) Treatment recommended for everyone Surgery with 5mm to 1cm without damage to clitoris, urethra, anus or other critical structures Ablative laser therapy with margin of 5mm to 1cm of normal skin (2mm deep), if hair bearing need to treat to base of follicles (down into subcutis) Imiquimod 5% 3x week for weeks, non responsive lesions are excised, close clinical followup after treatment 81% had complete or partial response
22 TREATMENTS HSIL Cidofovir 1% and 5FU are effective but have increased adverse effects Cidofovir trial in HIV+ patients Photodynamic therapy Sinecatechins - clinical trials nly
23 HSIL RECURRENCE Risk of recurrent disease increased Age>50 Multifocal disease Adjacent HPV or lichen sclerosus Immunosupression + excision margins Coexisting vaginal or cervical disease (VAIN or CIN) Satmary W. Gynecologic onc. 2018;148: (dvin and HSIL not differentiated)
24 NON HPV RELATED PRECURSOR LESIONS Differentiated VIN (dvin) Higher progression to SCC rate than HSIL (usual VIN) Elderly women Often associated with lichen sclerosus 1-3% of women with LS develop invasive SCC LS is present in 50% of women with SCC More than 50% of HPV unrelated SCC have adjacent dvin
25 DVIN IN LICHEN SCLEROSUS Rarely diagnosed except in excision specimens adjacent to invasive SCC
26 dvin in Lichen Sclerosus
27 B ASAL CELLS HYPERCHROMATIC PARAKERATOSIS DYSKERATOSIS PROMINENT INTERCELLULAR SPACES LOSS OF GRANULAR LAYER P53 STAINING MATCHES ADJACENT TUMOR
28 DVIN Enlarged vesicular nuclei Macro nucleoli Abundant eosinophilic cytoplasm
29 Invasive Squamous cell carcinoma (HPV related) HPV related SCC younger women (under age 60) 25% of invasive SCC HPV related 76% of HPV related SCC is warty or basaloid 33% well to moderately differentiated p16+ and HPV+ hallmark of HPV related SCC (HPV16-72%, HPV33-6%, HPV18-5%) (de Sanjose S et al. Worldwide human papillomavirus genotype attribution in over 2000 cases of intraepithelial and invasive lesions of the vulva. Eur J Cancer. 2013;49(16): )
30 INVASIVE SCC (HPV RELATED) Incidence is increasing world wide mirroring increase in HPV prevalence Interval between HSIL (usual VIN) to invasive SCC, shortens with increasing age (50 months for yrs, 25 months for age 70 yrs) No difference in time to progression to invasive SCC for multifocal vs unifocal disease
31 INVASIVE SQUAMOUS CELL CARCINOMA (HPV UNRELATED) HPV unrelated carcinomas, well to moderately differentiated SCC p53 mutation is the hallmark of HPV independent SCC 73% strong diffuse expression of p53 even above basal layer (mis sense mutation that leads to more stable protein) 27% of dvin and SCC have complete absence of p53 from nonsense mutation or deletion normal p53 staining - patchy p53 in basal layer More than 50% of HPV unrelated SCC have adjacent dvin Complete excision recommended of all hyperplastic vulvar lesions adjacent to SCC so p53 staining can be compared in lesional and nonlesional skin
32 LICHEN SCLEROSUS AND INVASIVE SCC Poorly controlled lichen sclerosus has much greater risk of progression to invasive SCC 507 women - observed 7 yrs, superpotent topical steroids 0 compliant pts, 7 partially compliant pts developed SCC manifested as treatment resistant hyperkeratotic plaques and nodules Incomplete disease control only risk for invasive SCC Even asymptomatic lichen sclerosus needs continuous maintenance therapy, such as mometasone furoate 0.1% (Lee A et al. Long-term management of adult vulvar lichen sclerosus: a prospective cohort study of 507 women. JAMA Dermatol. 2015;151(10): ) Unknown if lichen planus predisposes to vulvar SCC (Is vulvovaginal lichen planus associated with SCC? Day T et al. J of lower genital tract ds. 2018;22(2): ) Looked at all non HPV SCC of of vulva 95% of excisions had ls next to it, other 5% had LS in subsequent biopsies No evidence of LP
33 SCC IN LICHEN SCLEROSUS Treatment resistant hyperkeratotic plaque
34
35 SCC IN POORLY CONTROLLED LICHEN SCLEROSUS
36 SCC (HPV NON RELATED) Younger women (<50 yrs) more likely to have local disease Older women (>50) more likely to have regional disease or metastases Survival longer in younger women than older women even with same disease stage (5yr survival 87% <50 yrs, 53% > 50yrs) Local disease recurrence - Pathological margins margins <3mm - local recurrence 17% margins 3-8mm - local recurrence 25% margins >8mm - local recurrence 22% margin distance did not effect overall survival, only perineurial invasion influenced survival
37 SCC (HPV UNRELATED) Tumor size important prognostic indicator even with negative lymph nodes cm 5yr OS 79%, cm 78%, cm 36% Prognosis significantly declines if size of tumor >6cm One positive LN did not effect survival Two or more positive nodes experienced greater than 5 times higher risk of death than node negative patients Extra- capsular growth in lymph node metastasis increased the risk of death 5.2 times.
38 SQUAMOUS CELL CARCINOMA Re-excision of adjacent VIN (HSIL or dvin) in vulvar SCC did not change disease free survival Perhaps due second primaries due to existing risk factors for SCC (HPV or Lichen sclerosus) Impact of re-excision of residual adjacent VIN and histological tumor free margin on survival in primary SCC of vulva. Gasimli K et al. Archives Gyn and OB. 2018;298:
39 VULVAR PAGETS DISEASE (EXTRAMAMMARY) Average age 64 yrs Vulva (labia)most common site of extramammary Pagets disease Erythematous to hyperkeratotic plaques Symptom - pruritus Multifocal Median size 6.5cm Only 30% associated with underlying neoplasm Recurrence very common
40 PAGETS
41 PAGETS DISEASE Histology Pagets cells sit on top of basal layer Large cells with ample cytoplasm Vacuolated to clear cytoplasm Prominent nuclei and nucleoli PAS+ CEA+ EMA+ Cytokeratin 7+
42 EXTRAMAMMARY PAGETS DISEASE
43 OVERVIEW - TREATMENT OF PAGETS DISEASE Standard treatment - wide local excision (WLE) (2-3 cm margins) with XRT if LN+ (40-70% + resection margins) Laser - high rate of recurrence as may not reach adnexal extension Photodynamic (5 aminolevulinic acid) - high recurrence Radiation - appropriate dose unknown % recur, skin complications Imiquimod - recurrence 19%?????
44 TREATMENT OF PAGETS DISEASE Often do not recur (50% without further therapy) even with positive margins Could not predict invasive disease even with multiple scouting biopsies Recurrence most common in surgical scar from excision Increased recurrence if invasive disease present No evidence that microinvasive disease (invasion<1mm) decreases survival Risk of developing invasive disease is 8%
45 MOH S SURGERY VS WIDE LOCAL EXCISION MMS 12% 5 yr recurrence rate as opposed to 50% WLE recurrence rate, Wollina et al. Surgical treatment of extramammary Paget s disease. Curr ent Treatmetn Options in Oncol.2018;19:27. WLE 2.5x higher recurrence rate even with negative margins than MMS, Long et al. A matter of margins: surgical and pathological risk factors for recurrence in extramammary Paget s disease. Gynecologic oncology 2017;147: Damavandy A et al. CK7 immunostain during MMS decreases local recurrence from 26% to 3% (combined initial recurrent dx and disease with first treatment)
46 IMIQUIMOD ADVERSE EFFECTS Targets Toll like receptor 7 (TLR7) of dendritic and Langerhan cells Release INF, TNF, IL-12 which activates CD8+ cells Apoptosis of transformed cells Application 5-7x week - 82% adverse effects causing frequency reduction 3-4x week - 2 % adverse effects causing frequency reduction 1-2x week - 0 % adverse effects causing frequency reduction Treatment duration 4 months 73% CR 27% PR or stable disease 0% progression
47 IMIQUIMOD RESULTS Complete response versus Partial response No difference in age No difference in primary vs recurrent disease No difference in tumor size No difference in treatment duration
48 PAGETS THERAPY - TAKE HOME MESSAGE Surgery often mutilating with significant decrease in quality of life Recurrence rate for all therapies HIGH (perhaps less with MMS) Use imiquimod 3-4 x week as sole therapy If using surgery, consider imiquimod prior to surgery to decrease size of tumor Life long follow up Low threshold to biopsy for recurrent disease
49 TAKE HOME MESSAGES Many pigmented vulvar lesions are indistinguishable clinically Low threshold for biopsy LONG TERM MONITORING ESSENTIAL Lichen sclerosus Vulvar melanosis Pagets disease
50 TAKE HOME MESSAGES Lichen Sclerosus requires maintenance therapy to reduce risk of SCC Paget s disease and Lichen Sclerosus Low threshold to biopsy - new or non responsive areas Baseline photographs Vulvar melanosis Low threshold to biopsy - new or non responsive areas Baseline photographs
51 THANKS TO DR. LYNNE MARGESSON, AND ISSVD LIBRARY FOR PHOTOS. References 1. Ribe A. Melanocytic lesions of the genital area with attention given to atypical genital nevi. J Cutan Pathol 2008;35(2): Edwards L. Pigmented vulvar lesions. Dermatol Ther. 2010;23(5): Lenane P et al. Genital melanotic macules: clinical, histologic, immunohistochemical, and ultrastructural features. J Am Acad Dermatol. 2000;42(4): Gleason BC et al. Atypical genital nevi. A clinicopathologic analysis of 56 cases. Am J Surg Pathol. 2008;32(1): Shabrawi-Caelen E et al. Genital lentigines and melanocytic nevi with superimposed lichen sclerosus: a diagnostic challenge. J Am Acad Dermatol. 2004;50(5): Murzaku EC et al. Vulvar nevi, melanosis, and melanoma: an epidemiologic, clinical, and histopathologic review. J Am Acad Dermatol. 2014;71(6): Ferrari A et al. The ringlike pattern in vulvar melanosis: a new dermoscopic clue for diagnosis. Arch Dermatol. 2008;144(8): Chokoeva AA et al. Vulvar cancer: a review for dermatologists. Wien Med Wochenschr. 2015;165(7-8):
52 9. Tseng D et al. Oncogenic mutations in melanomas and benign melanocytic nevi of the female genital tract. J Am Acad Dermatol. 2014;71(2): Rouzbahman M et al. Malignant Melanoma of Vulva and Vagina: A Histomorphological Review and Mutation Analysis--A Single-Center Study. J Low Genit Tract Dis Oct;19(4): Handolias Det al. Mutations in KIT occur at low frequency in melanomas arising from anatomical sites associated with chronic and intermittent sun exposure. Pigment Cell Melanoma Res. 2010;23(2): Romany AN et al. Molecular Targeted Therapy Approaches for BRAF Wild- Type Melanoma. Curr Oncol Rep 2016:18:6 13. Bornstein J et al.the 2015 International Society for the Study of Vulvovaginal Disease (ISSVD) Terminology of Vulvar Squamous Intraepithelial Lesions. J Low Genit Tract Dis Jan;20(1): de Sanjose S et al. Worldwide human papillomavirus genotype attribution in over 2000 cases of intraepithelial and invasive lesions of the vulva. Eur J Cancer. 2014;49(16): Gupta N et al. A case report of vulvar carcinoma in situ treated with sinecatechins with complete response. Gynecol Oncol Case Rep. 2013;1(6): Scurry J. Wilkinson EJ. Review of Terminology of precursors of Vulvar squamous cell carcinoma. J Low Genit Tract Dis. 2006;10(3):161-9.
53 17. Singh N et al. Expanding the morphologic spectrum of differentiated VIN (dvin) through detailed mapping of cases with p53 loss. Am J Surg Pathol. 2015;39(1): Al-Ghamdi A et al. Vulvar squamous cell carcinoma in young women: a clinicopathologic study of 21 cases. Gynecol Oncol. 2002;84(1): van de Nieuwenhof HP et al. Vulvar squamous cell carcinoma development after diagnosis of VIN increases with age. Eur J Cancer. 2009;45(5): Jones RW et al. "Is the assumed natural history of vulvar intraepithelial neoplasia III based on enough evidence? A systematic review of 3322 published patients. Gynecol Oncol. 2006;101(2): Lee A et al. Long-term management of adult vulvar lichen sclerosus: a prospective cohort study of 507 women. JAMA Dermatol. 2015;151(10): Cooper SM et al. Reduced Risk of Squamous Cell Carcinoma With Adequate Treatment of Vulvar Lichen Sclerosus. JAMA Dermatol. 2015;151(10): Baiocchi G et al. Vulvar cancer surgery. Curr Opin Obstet Gynecol. 2014;26(1): Tristram A et al. Clinical responses to Cidofovir applied topically to women with high grade vulvar intraepithelial neoplasia. Gynecol Oncol 2005; 99: van Seters M et al. Treatment of vulvar intraepithelial neoplasia with topical imiquimod. N Engl J Med 2008; 358: Stier E et al. Safety and efficacy of topical cidofovir to treat high-grade perianal and vulvar intraepithelial neoplasia in HIV-positive men and women. AIDS 2013;27(4): The Committee on Gynecologic Practice of the American College of Obstetricians and Gynecologists and the American Society for Colposcopy and Cervical Pathology. Management of Vulvar Intraepithelial Neoplasia J Low Genit Tract Dis. 2012; 16(1): Jones, RW. Vulvar Intraepithelial Neoplasia: Aspects of the Natural History and Outcome in 405 Women. Obstet Gynecol. 2005;106(6):
54 30. Aragona AM et al. An analysis of reported independent prognostic factors for survival in squamous cell carcinoma of the vulva: is tumor size significance being underrated? Gynecol Oncol. 2014;132(3): Kumar S et al. A comparison of younger vs older women with vulvar cancer in the United States. Am J Obstet Gynecol. 2009;200(5):e Baiocchi G et al. How important is the pathological margin distance in vulvar cancer? Eur J Surg Oncol. 2015;41(12): Nomura H et al. Clinicopathologic features and treatment outcomes of primary extramammary Paget disease of the vulva. J Low Genit Tract Dis. 2015;19(2): Layton A et al. Treatment of extramammary Paget disease of the vulva with imiquimod: a retrospective, multicenter study by the German Colposcopy Network. J Am Acad Dermatol. 2014;70(4): Van der Putte SC et al. Clear cells of Toker in the developing anogenital region of male and female fetuses. Am J Dermatopathol. 2011;33(8): Gonclaves A et al. Paget Disease of the Vulva: Diagnosis by Immunohistochemistry. Case Rep Dermatol Med. 2015;2015: Machida H et al. Effects of imiquimod on vulvar Paget's disease: a systematic review of literature. Gynecol Oncol. 2015;139(1):
Treatment of Bowenoid and Basaloid Vulvar Intraepithelial Neoplasia 2/3 with Imiquimod 5% Cream DO NOT DUPLICATE
The Journal of Reproductive Medicine Treatment of Bowenoid and Basaloid Vulvar Intraepithelial Neoplasia 2/3 with Imiquimod 5% Cream Claudia Marchitelli, M.D., Graciela Secco, M.D., Myriam Perrotta, M.D.,
More informationVIN/VAIN O C T O B E R 3 RD J M O R G A N
VIN/VAIN O C T O B E R 3 RD 2 0 1 8 J M O R G A N Vaginal Intraepithelial Neoplasia VAIN I, II, III Incidence 0.1/100,000 women in US Mean age 50s (J Womens Health (Larchmt) 2009:18:1731) (J Obstet Gynaecol
More informationPRINCESS MARGARET CANCER CENTRE CLINICAL PRACTICE GUIDELINES GYNECOLOGIC CANCER VULVAR
PRINCESS MARGARET CANCER CENTRE CLINICAL PRACTICE GUIDELINES GYNECOLOGIC CANCER VULVAR Last Revision Date July 2015 1 Site Group: Gynecologic Cancer Vulvar Author: Dr. Stephane Laframboise 1. INTRODUCTION
More informationClinical characteristics
Skin Cancer Fernando Vega, MD Seattle Healing Arts Clinical characteristics Precancerous lesions Common skin cancers ACTINIC KERATOSIS Precancerous skin lesions Actinic keratoses Dysplastic melanocytic
More informationDisorders of the vulva
Vulval lesions Disorders of the vulva Terminology standardised by the International Society for the Study of Vulvovaginal Disease(ISSVD) Classification 1.Nonneoplastic epithelial disorders of vulva Lichen
More informationDermatopathology: The tumor is composed of keratinocytes which show atypia, increase mitoses and abnormal mitoses.
Squamous cell carcinoma (SCC): A common malignant tumor of keratinocytes arising in the epidermis, usually from a precancerous condition: 1- UV induced actinic keratosis, usually of low grade malignancy.
More informationTime series analysis of TP53 gene mutations in recurrent HPV-negative vulvar squamous cell carcinoma
Time series analysis of TP53 gene mutations in recurrent HPV-negative vulvar squamous cell carcinoma Karl Kashofer, Phd Institut für Pathologie Medizinische Universität Graz Disclosures Member of Clinical
More informationWhen Immunostains Can Get You in Trouble: Gynecologic Pathology p16: Panacea or Pandora s Box?
When Immunostains Can Get You in Trouble: Gynecologic Pathology p16: Panacea or Pandora s Box? Teri A. Longacre, MD Stanford Medicine Stanford California pi6 in Gynecologic Pathology: Panacea or Pandora
More informationVulvar squamous cell carcinoma
The Clinical Significance of Stratifying Vulval Squamous Carcinoma into HPV and Non-HPV Related Variants C. BLAKE GILKS MD FRCPC Dept of Pathology, University of British Columbia Vulvar squamous cell carcinoma
More informationDiseases of the vulva
Diseases of the vulva 1. Bartholin Cyst - Infection of the Bartholin gland produces an acute inflammation within the gland (adenitis) and may result in an abscess. Bartholin duct cysts - Are relatively
More informationVulvar Carcinoma. Definition: Cases should be classified as carsinoma of the vulva when the primary site growth is in the vulva Malignant melanoma sho
Carcinoma Vulva & Vagina Subdivisi Onkologi Ginekologi Bagian Obgin FK USU Vulvar Carcinoma. Definition: Cases should be classified as carsinoma of the vulva when the primary site growth is in the vulva
More informationVULVAR CARCINOMA. Page 1 of 5
VULVAR CARCINOMA EXAMPLE OF A VULVAR CARCINOMA USING PROPOSED TEMPLATE Case: Invasive squamous cell carcinoma arising in D-VIN Tumor in left labia major Left partial vaginectomy and sentinel lymph node
More informationMULLERIAN PAPILLOMA ENTITY RECOGNITION FAILURE 04/04/2016 OUT OF SIGHT, OUT OF MIND: LESSER KNOWN LESIONS OF THE VULVOVAGINAL TRACT
OUT OF SIGHT, OUT OF MIND: LESSER KNOWN LESIONS OF THE VULVOVAGINAL TRACT 23 rd ANNUAL SEMINAR IN PATHOLOGY 30 APRIL 2016 W. Dwayne Lawrence MD MSc (Path.) Chief of Pathology and Laboratory Medicine Women
More informationVulvar Disease Clinical Cases
Vulvar Disease Clinical Cases Hope K. Haefner, MD Professor University of Michigan Health System February 27, 2015 Cartagena Conflicts of Interest Hope Haefner, MD is on the Advisory Board of Merck Co.,
More informationBenign and malignant epithelial lesions: Seborrheic keratosis: A common benign pigmented epidermal tumor occur in middle-aged or older persons more
Benign and malignant epithelial lesions: Seborrheic keratosis: A common benign pigmented epidermal tumor occur in middle-aged or older persons more common on the trunk; but extremities, head and neck are
More informationHuman Papillomavirus
Human Papillomavirus Dawn Palaszewski, MD Assistant Professor of Obstetrics and Gynecology University of February 18, 2018 9:40 am Dawn Palaszewski, MD Assistant Professor Department of Obstetrics and
More informationAn Overview of Melanoma. Harriet Kluger, M.D. Associate Professor Section of Medical Oncology Yale Cancer Center
An Overview of Melanoma Harriet Kluger, M.D. Associate Professor Section of Medical Oncology Yale Cancer Center Melanoma Statistics Median age at presentation 45-55 55 years Incidence: 2003 54,200 cases
More informationVulvar intraepithelial neoplasia: Current concepts
Vulvar intraepithelial neoplasia: Current concepts L. Stewart Massad, M.D. Dept. of Obstetrics & Gynecology Washington University School of Medicine St. Louis, MO Disclosure I have no financial ties to
More informationClinically Microscopically Pathogenesis: autoimmune not lifetime
Vulvar Diseases: Can be divided to non-neoplastic and neoplastic diseases. The neoplastic diseases are much less common. Of those, squamous cell carcinoma is the most common. most common in postmenopausal
More informationBAP-oma & BEYOND MICHAEL A NOWAK, MD
BAP-oma & BEYOND MICHAEL A NOWAK, MD CONFLICTS No conflicts with the content of this lecture BAP-oma Wiesner 2011: Families with multiple tan dome-shaped papules of head, neck, trunk, and extremities.
More informationHuman Papillomavirus Induced Squamous Intraepithelial Lesions in Vulvar Lichen Planus
ORIGINAL RESEARCH ARTICLE Human Papillomavirus Induced Squamous Intraepithelial Lesions in Vulvar Lichen Planus Sigrid Regauer, MD, 1 Barbara Eberz, MD, 2 and Olaf Reich, MD 3 Objectives: Approximately
More informationIdentifying Skin Cancer. Mary S. Stone MD Professor of Dermatology and Pathology University of Iowa Carver College of Medicine March, 2018
Identifying Skin Cancer Mary S. Stone MD Professor of Dermatology and Pathology University of Iowa Carver College of Medicine March, 2018 American Cancer Society web site Skin Cancer Melanoma Non-Melanoma
More informationAsymptomatic Undiagnosed Lichen Sclerosus
Asymptomatic Undiagnosed Lichen Sclerosus Lynette J. Margesson MD FRCPC Assistant Professor of Obstetrics & Gynecology and Surgery(Dermatology) Geisel School of Medicine at Dartmouth Lebanon, NH, USA Disclosures
More informationIT S FUNDAMENTAL MY DEAR WATSON! A SHERLOCKIAN APPROACH TO DERMATOLOGY
IT S FUNDAMENTAL MY DEAR WATSON! A SHERLOCKIAN APPROACH TO DERMATOLOGY Skin, Bones, and other Private Parts Symposium Dermatology Lectures by Debra Shelby, PhD, DNP, FNP-BC, FADNP, FAANP Debra Shelby,
More informationUpdate of the role of Human Papillomavirus in Head and Neck Cancer
Update of the role of Human Papillomavirus in Head and Neck Cancer 2013 International & 12 th National Head and Neck Tumour Conference Shanghai, 11 13 Oct 2013 Prof. Paul KS Chan Department of Microbiology
More informationAppropriate Use of Cytology and HPV Testing in the New Cervical Cancer Screening Guidelines
Appropriate Use of Cytology and HPV Testing in the New Cervical Cancer Screening Guidelines Tim Kremer, MD Ralph Anderson, MD 1 Objectives Describe the natural history of HPV particularly as it relates
More informationRegression 2/3/18. Histologically regression is characterized: melanosis fibrosis combination of both. Distribution: partial or focal!
Regression Margaret Oliviero MSN, ARNP Harold S. Rabinovitz MD Histologically regression is characterized: melanosis fibrosis combination of both Distribution: partial or focal! Dermatoscopic terminology
More informationDisclosures. I have no conflicts of interest to disclose. Vulvar Disease. Precancer and Cancerous Vulvar Disease
Precancer and Cancerous Vulvar Disease Stefanie M. Ueda, M.D. Disclosures I have no conflicts of interest to disclose. Assistant Clinical Professor Division of Gynecologic Oncology University of California,
More informationBenign versus Cancerous Lesions How to tell the difference FMF 2014 Christie Freeman MD, CCFP, DipPDerm, MSc
1 Benign versus Cancerous Lesions How to tell the difference FMF 2014 Christie Freeman MD, CCFP, DipPDerm, MSc Benign lesions Seborrheic Keratoses: Warty, stuck-on Genetics and birthdays Can start in late
More informationPenile cancer teams in UK. Common variants. Penile cancer teams. Basaloid squamous carcinoma. The Pathology of Penile Tumours
The Pathology of Penile Tumours Dr Jonathan H Shanks The Christie NHS Foundation Trust, Manchester, UK Penile cancer teams in UK 12 centres for penile cancer work (10 in England and Wales, 2 in Scotland)
More informationChapter 6 Squamous Cell Carcinoma: Variants and Challenges
Chapter 6 Squamous Cell Carcinoma: Variants and Challenges Michael B. Morgan EPIDEMIOLOGY: Second most common skin cancer, rare in the dark-skinned races. ETIOLOGY: Ultraviolet light, HPV infection. PATHOGENESIS:
More informationHistopathology: Cervical HPV and neoplasia
Histopathology: Cervical HPV and neoplasia These presentations are to help you identify basic histopathological features. They do not contain the additional factual information that you need to learn about
More informationPathology of the skin. 2nd Department of Pathology, Semmelweis University
Pathology of the skin 2nd Department of Pathology, Semmelweis University Histology of the skin Epidermis: Stratum corneum Stratum granulosum Stratum spinosum Stratum basale Dermis: papillary and reticular
More informationAcantholytic Anaplastic Extramammary Paget s Disease: A Case Report and Review of the Literature
Ann Dermatol Vol. 23, Suppl. 2, 2011 http://dx.doi.org/10.5021/ad.2011.23.s2.s226 CASE REPORT Acantholytic Anaplastic Extramammary Paget s Disease: A Case Report and Review of the Literature Yu-Jin Oh,
More informationSimulators of melanoma
Simulators of melanoma Philip E. LeBoit, M.D. Depts. of Pathology and Dermatology University of California, San Francisco Simulators of melanoma Simulators of melanoma in situ Melanocytic Non-melanocytic
More information1.Acute and Chronic Cervicitis - At the onset of menarche, the production of estrogens by the ovary stimulates maturation of the cervical and vaginal
Diseases of cervix I. Inflammations 1.Acute and Chronic Cervicitis - At the onset of menarche, the production of estrogens by the ovary stimulates maturation of the cervical and vaginal squamous mucosa
More informationLessons From Cases of Screened Women Who Developed Cervical Carcinoma
Lessons From Cases of Screened Women Who Developed Cervical Carcinoma R. Marshall Austin MD,PhD Magee-Womens Hospital of University of Pittsburgh Medical Center raustin@magee.edu Why Focus Study On Cases
More informationSENTINEL NODES FOR EARLY VULVAL CANCER:
SENTINEL NODES FOR EARLY VULVAL CANCER: FEASIBILITY AND SAFETY IN A LOW RESOURCE SETTING LINDA ROGERS RCOG Congress 2017 None Declaration of Interests Vulval Cancer Rare 4% of all gynaecological malignancies
More informationSkin Malignancies Non - Melanoma & Melanoma Marilyn Ng, MD Dept. of Surgery M&M Conference Downstate Medical Center July 19, 2012
Skin Malignancies Non - Melanoma & Melanoma Marilyn Ng, MD Dept. of Surgery M&M Conference Downstate Medical Center July 19, 2012 Case Presentation 57 yo man with 3 month hx of a nonhealing < 1 cm right
More informationObjectives. Atypical Glandular Cells. Atypical Endocervical Cells. Reactive Endocervical Cells
2013 California Society of Pathologists 66 th Annual Meeting San Francisco, CA Atypical Glandular Cells to Early Invasive Adenocarcinoma: Cervical Cytology and Histology Christina S. Kong, MD Associate
More informationKnow who is at risk: LOOK! for ABCDs, rapidly changing lesions, do a biopsy when indicated
Lindy P. Fox, MD Assistant Professor Director, Hospital Consultation Service Department of Dermatology University of California, San Francisco Applies to adults without history of malignancy or premalignant
More informationMalignant Melanoma Early Stage. A guide for patients
This melanoma patient brochure is designed to help educate melanoma patients and their caregivers. It was developed under the guidance of Dr. Michael Smylie, Professor, Department of Oncology, University
More informationClinical Pathological Conference. Malignant Melanoma of the Vulva
Clinical Pathological Conference Malignant Melanoma of the Vulva History F/48 Chinese Married Para 1 Presented in September 2004 Vulval mass for 2 months Associated with watery and blood stained discharge
More informationSkin Cancer. 5 Warning Signs. American Osteopathic College of Occupational and Preventive Medicine OMED 2012, San Diego, Monday, October 8, 2012 C-1
Skin Cancer AMERICAN OSTEOPATHIC COLLEGE OF OCCUPATIONAL & PREVENTIVE MEDICINE OMED 2012 October 8, 2012 E. Robert Wanat II, D.O., M.P.H. Learning Objectives: Identify the 3 Basic Types of Skin Cancer
More information3/25/2019. J. Anthony Rakowski D.O., F.A.C.O.O.G. MSU SCS Board Review Coarse
J. Anthony Rakowski D.O., F.A.C.O.O.G. MSU SCS Board Review Coarse 1 4 th most common GYN cancer 5% of malignancies of GYN type. 4850 new cases annually 1030 deaths Cigarette smoking Vulvar dystrophy (Lichen
More informationDesmoplastic Melanoma R/O BCC. Clinical Information. 74 y.o. man with lesion on left side of neck r/o BCC
R/O BCC Sabine Kohler, M.D. Professor of Pathology and Dermatology Dermatopathology Service Stanford University School of Medicine Clinical Information 74 y.o. man with lesion on left side of neck r/o
More informationHPV-related papillomatous-condylomatous lesions in female anogenital area
HPV-related papillomatous-condylomatous lesions in female anogenital area Theo Panoskaltsis MD, FRCOG, CCST (UK) Epidemiology Anal cancer is increasing in both men and women Groups at risk: - HIV (+)
More informationPathology of the Cervix
Pathology of the Cervix Thomas C. Wright Pathology of the Cervix Topics to Consider Burden of cervical cancer 1 Invasive Cervical Cancer Cervical cancer in world Second cause of cancer death in women Leading
More informationCutaneous Malignancies: A Primer COPYRIGHT. Marissa Heller, M.D.
Cutaneous Malignancies: A Primer Marissa Heller, M.D. Associate Director of Dermatologic Surgery Department of Dermatology Beth Israel Deaconess Medical Center December 10, 2016 Skin Cancer Non-melanoma
More informationVaginal involvement in genital erosive lichen planus
Acta Obstetricia et Gynecologica. 2010; 89: 966 970 SHORT REPORT Vaginal involvement in genital erosive lichen planus ANNE LISE ORDING HELGESEN 1,2,3, PETTER GJERSVIK 3,4, PETER JEBSEN 5, ROLF KIRSCHNER
More informationCASE 4 21/07/2017. Ectopic Prostatic Tissue in Cervix. Female 31. LLETZ for borderline nuclear abnormalities
Female 31 CASE 4 LLETZ for borderline nuclear abnormalities PSA Ectopic Prostatic Tissue in Cervix AJSP 2006;30;209-215 usually incidental microscopic finding usually in ectocervical stroma? developmental
More informationGenital Lesions in Dermatopathology
Genital Lesions in Dermatopathology Janis M. Taube, MD Director of Dermatopathology Associate Professor of Dermatology and Pathology Johns Hopkins University SOM Overview Vulvovaginal pathology Inflammatory
More informationGenital Lesions in Dermatopathology
Genital Lesions in Dermatopathology Janis M. Taube, MD Director of Dermatopathology Associate Professor of Dermatology and Pathology Johns Hopkins University SOM Overview Vulvovaginal lesions Non-Neoplastic
More informationClinical Scoring System to Detect Malignant and Premalignant Vulval Lesions
The Journal of Obstetrics and Gynecology of India (January February 2014) 64(1):41 46 DOI 10.1007/s13224-013-0458-3 ORIGINAL ARTICLE Clinical Scoring System to Detect Malignant and Premalignant Vulval
More informationDiagnostic difficulties with lesions of the oral mucosa
BDIAP London, November 2010 School of Clinical Dentistry University of Sheffield Diagnostic difficulties with lesions of the oral mucosa Paul M Speight Dept Oral & Maxillofacial Pathology University of
More informationKnow who is at risk: LOOK! for ABCDs, rapidly changing lesions, do a biopsy when indicated
Lindy P. Fox, MD Associate Professor Director, Hospital Consultation Service Department of Dermatology University of California, San Francisco Applies to adults without history of malignancy or premalignant
More informationMaligna Melanoma and Atypical Fibroxanthoma: An Unusual Collision Tumour G Türkcü 1, A Keleş 1, U Alabalık 1, D Uçmak 2, H Büyükbayram 1 ABSTRACT
Maligna Melanoma and Atypical Fibroxanthoma: An Unusual Collision Tumour G Türkcü 1, A Keleş 1, U Alabalık 1, D Uçmak 2, H Büyükbayram 1 ABSTRACT Two different neoplasia in the same biopsy material called
More informationأملس عضلي غرن = Leiomyosarcoma. Leiomyosarcoma 1 / 5
Leiomyosarcoma 1 / 5 EPIDEMIOLOGY Exact incidence is unknown, but older studies suggest that leiomyosarcomas comprise approximately 3 percent of soft-tissue sarcomas. Superficial leiomyosarcoma occurs
More informationSyddansk Universitet. Melanomas of the vulva and vagina. Skovsted, Sasia; Nielsen, Karsten; Blaakær, Jan. Published in: Danish Medical Journal
Syddansk Universitet Melanomas of the vulva and vagina Skovsted, Sasia; Nielsen, Karsten; Blaakær, Jan Published in: Danish Medical Journal Publication date: 2017 Document version Publisher's PDF, also
More informationEpidemiology, diagnosis and treatment of vulvar intraepithelial neoplasia Elmar A. Joura
Epidemiology, diagnosis and treatment of vulvar intraepithelial neoplasia Elmar A. Joura The incidence of human papilloma virus-related vulvar intraepithelial neoplasia is increasing worldwide. This is
More informationLiving Beyond Cancer Skin Cancer Detection and Prevention
Living Beyond Cancer Skin Cancer Detection and Prevention Cutaneous Skin Cancers Identification Diagnosis Treatment options Prevention What is the most common cancer in people? What is the most common
More informationSESSION J4. What's Next? Managing Abnormal PAPs in 2014
37th Annual Advanced Practice in Primary and Acute Care Conference: October 9-11, 2014 2:45 SESSION J4 What's Next? Managing Abnormal PAPs in 2014 Session Description: Linda Eckert, MD Review current guidelines
More informationVulva Cancer Histopathology Reporting Proforma
Vulva Cancer Histopathology Reporting Proforma Mandatory questions (i.e. protocol standards) are in bold (e.g. S1.01). S1.01 Identification Family name Given name(s) Ethnicity Unknown AboriginalTorres
More informationMEDICAL POLICY SUBJECT: HIGH RESOLUTION ANOSCOPY
MEDICAL POLICY SUBJECT: HIGH RESOLUTION ANOSCOPY PAGE: 1 OF: 5 If a product excludes coverage for a service, it is not covered, and medical policy criteria do not apply. If a commercial product (including
More informationMaking Sense of Cervical Cancer Screening
Making Sense of Cervical Cancer Screening New Guidelines published November 2012 Tammie Koehler DO, FACOG The incidence of cervical cancer in the US has decreased more than 50% in the past 30 years because
More informationUpdate on Cutaneous Mesenchymal Tumors. Thomas Brenn
Update on Cutaneous Mesenchymal Tumors Thomas Brenn Cutaneous Mesenchymal Tumours Wide morphological and biological spectrum Myofibroblastic, smooth muscle, neural, vascular, apidocytic, undifferentiated;
More informationWoo Dae Kang, Ho Sun Choi, Seok Mo Kim
Is vaccination with quadrivalent HPV vaccine after Loop Electrosurgical Excision Procedure effective in preventing recurrence in patients with High-grade Cervical Intraepithelial Neoplasia (CIN2-3)? Chonnam
More informationEvaluation of 6 Patients with Genital Melanoma from Onset of Symptoms to Death: Evaluate the Factors Affecting the Prognosis of the Disease
ORIGINAL PAPER doi: 10.5455/medarh.2015.69.293-297 Med Arh. 2015 Oct; 69(5): 293-297 Received: July 15th 2015 Accepted: September 15th 2015 2015 Marjan Shokrani This is an Open Access article distributed
More information04/09/2018. Squamous Cell Neoplasia and Precursor Lesions. Agenda. Squamous Dysplasia. Squamo-proliferative lesions. Architectural features
Squamous Cell Neoplasia and Precursor Lesions Jennifer L. Hunt, MD, MEd Aubrey J. Hough Jr, MD, Endowed Professor of Pathology Chair of Pathology and Laboratory Medicine University of Arkansas for Medical
More informationNEOPLASMS OF THE SURFACE EPITHELIUM (KERATINOCYTES)
NEOPLASMS OF THE SURFACE EPITHELIUM (KERATINOCYTES) Papillary Lesions Precancerous Lesions Keratinocyte Proliferations Carcinomas Melanotic Lesions Melanomas Normal Mucosa Keratin layer Spinous layer Basal
More informationDermatopathology. Dr. Rafael Botella Estrada. Hospital La Fe de Valencia
Dermatopathology Dr. Rafael Botella Estrada. Hospital La Fe de Valencia Melanoma and mimics Dr. Martin Mihm Malignant lesions result from the accumulation of mutations Class I lesions (benign) Class II
More informationMEDICAL POLICY EFFECTIVE DATE: 12/20/12 REVISED DATE: 11/21/13, 10/16/14 SUBJECT: HIGH RESOLUTION ANOSCOPY
MEDICAL POLICY PAGE: 1 OF: 5 If the member's subscriber contract excludes coverage for a specific service it is not covered under that contract. In such cases, medical policy criteria are not applied.
More informationGlenn D. Goldman, MD. University of Vermont Medical Center. University of Vermont College of Medicine
Glenn D. Goldman, MD University of Vermont Medical Center University of Vermont College of Medicine Recognize and identify the main types of skin cancer and their precursors Identify and understand new
More informationCarcinomas escamosos de vulva y vagina. Relación con HPV
Carcinomas escamosos de vulva y vagina. Relación con HPV Dr. Jaume Ordi Servei d Anatomia Patològica Hospital Clínic. Barcelona jordi@clinic.ub.es - 1 - Carcinoma de cérvix y VPH International Biological
More informationHistopathology of Melanoma
THE YALE JOURNAL OF BIOLOGY AND MEDICINE 48, 409-416 (1975) Histopathology of Melanoma G. J. WALKER SMITH Department ofpathology, Yale University School ofmedicine, 333 Cedar Street, New Haven, Connecticut
More informationMohs surgery for the nail unit
Mohs surgery for the nail unit olivier.cogrel@chu-bordeaux.fr Dermatologic surgery, Mohs surgery and lasers unit CHU Bordeaux, France Squamous cell carcinoma +++ Acral lentiginous melanoma Lichte et al.
More informationPeriocular Malignancies
Periocular Malignancies Andrew Gurwood, O.D., F.A.A.O., Dipl. Marc Myers, O.D., F.A.A.O. Drs. Myers and Gurwood have no financial interests to disclose. Course Description Discussion of the most common
More informationCase history: Figure 1. H&E, 5x. Figure 2. H&E, 20x.
1 Case history: A 49 year-old female presented with a 5 year history of chronic anal fissure. The patient s past medical history is otherwise unremarkable. On digital rectal examination there was a very
More informationDermatology for the PCP Deanna G. Brown, MD, FAAD Susong Dermatology Consulting Staff at CHI Memorial
Dermatology for the PCP Deanna G. Brown, MD, FAAD Susong Dermatology Consulting Staff at CHI Memorial Cutaneous Oncology for the PCP Deanna G. Brown, MD, FAAD Susong Dermatology Consulting Staff at CHI
More informationGlenn D. Goldman, MD. Fletcher Allen Health Care. University of Vermont College of Medicine
Glenn D. Goldman, MD Fletcher Allen Health Care University of Vermont College of Medicine Recognize and identify the main types of skin cancer Understand how and why Mohs surgery is utilized for the treatment
More informationCutaneous Adnexal Tumors
Cutaneous Adnexal Tumors Lesions with Predominant Follicular Differentiation Special Emphasis on Basal Cell Carcinoma 2014-04-01 Prof. Dr. med. Katharina Glatz Pathologie Cutaneous Adnexal Tumors Hair
More informationPatricia Chevez-Barrrios AAOOP-USCAP /12/2016
Biomarkers in Ocular Melanoma Patricia Chévez-Barrios, MD Pathology and Genomic Medicine, Houston Methodist Hospital Professor of Pathology and Laboratory Medicine and Ophthalmology, Weill Cornell Medical
More informationPRE TEST CERVICAL SCREENING MANAGEMENT COLPOSCOPY PATHOLOGIC DIAGNOSIS AND TREATMENT
PRE TEST CERVICAL SCREENING MANAGEMENT COLPOSCOPY PATHOLOGIC DIAGNOSIS AND TREATMENT QUESTION #1 WHICH OF THE FOLLOWING IS NOT A RISK FACTOR FOR CERVICAL CANCER? A. HIGH RISK HPV B. CIGARETTE SMOKING C.
More informationBasal cell carcinoma 5/28/2011
Goal of this Presentation A practical approach to the diagnosis of cutaneous carcinomas and their mimics Thaddeus Mully, MD University of California San Francisco To review common non-melanoma skin cancers
More informationORAL MELANOMA Definition Epidemiology Clinical Presentation
ORAL MELANOMA Definition Melanoma is a highly malignant neoplasia, arising from melanocytes, the cells that produce the brownish pigment melanin. Melanin is the determinant in skin colour and protects
More informationWe are IntechOpen, the world s leading publisher of Open Access books Built by scientists, for scientists. International authors and editors
We are IntechOpen, the world s leading publisher of Open Access books Built by scientists, for scientists 3,500 108,000 1.7 M Open access books available International authors and editors Downloads Our
More informationA PRACTICAL APPROACH TO ATYPICAL MELANOCYTIC LESIONS BIJAN HAGHIGHI M.D, DIRECTOR OF DERMATOPATHOLOGY, ST. JOSEPH HOSPITAL
A PRACTICAL APPROACH TO ATYPICAL MELANOCYTIC LESIONS BIJAN HAGHIGHI M.D, DIRECTOR OF DERMATOPATHOLOGY, ST. JOSEPH HOSPITAL OBJECTIVES Discuss current trends and changing concepts in our understanding of
More informationToby Maurer, MD University of California, San Francisco. Lifetime risk of an American developing melanoma
Distinguishing Pigmented Skin Lesions and Melanoma Toby Maurer, MD University of California, San Francisco Epidemiology of Melanoma Lifetime risk of an American developing melanoma 1935: 1 in 1500 1980:
More informationTechnicians & Nurses Program
ASCRS ASOA Symposium & Congress Technicians & Nurses Program May 6-10, 2016 New Orleans Evaluation and Treatment of Eyelid Malignancies Richard C. Allen MD PhD FACS Professor Section of Ophthalmology Dept.
More informationHPV infections and potential outcomes
CONTENTS Preface by Silvia de Sanjosé... 33 Preface by Jacob Bornstein... 37 Author s note... 39 Acknowledgments... 45 CHAPTER 1 HPV infections and potential outcomes HPV: What it is, where it is and what
More informationToby Maurer, MD University of California, San Francisco. Lifetime risk of an American developing melanoma
Distinguishing Pigmented Skin Lesions and Melanoma Toby Maurer, MD University of California, San Francisco Epidemiology of Melanoma Lifetime risk of an American developing melanoma 1935: 1 in 1500 1980:
More informationMeet the ISSVD. President ISSVD. Jacob Bornstein, MD
Meet the ISSVD Jacob Bornstein, MD President ISSVD Chairman, Department of Obstetrics and Gynecology Western Galilee Hospital Bar-Ilan University Faculty of Medicine Nahariya, Israel ISSVD Symposium: The
More informationVaginal intraepithelial neoplasia
Vaginal intraepithelial neoplasia The terminology and pathology of VAIN are analogous to those of CIN (VAIN I-III). The main difference is that vaginal epithelium does not normally have crypts, so the
More informationLUMPS AND BUMPS: AN ORGANIZED APPROACH TO DIAGNOSIS AND MANAGEMENT
LUMPS AND BUMPS: AN ORGANIZED APPROACH TO DIAGNOSIS AND MANAGEMENT Tammy P. Than, M.S., O.D., F.A.A.O. The University of Alabama at Birmingham / School of Optometry 1716 University Blvd. Birmingham, AL
More informationMelanoma Update: 8th Edition of AJCC Staging System
Melanoma Update: 8th Edition of AJCC Staging System Rosalie Elenitsas, M.D. Professor of Dermatology Director, Dermatopathology University of Pennsylvania DISCLOSURE OF RELATIONSHIPS WITH INDUSTRY None
More informationOCCG SERVICE SPECIFICATION (2017/18)
OCCG SERVICE SPECIFICATION (2017/18) Primary Care Service for Skin Cancers: Dermatology Shared Care Monitoring for Melanoma, Lichen Sclerosus and Squamos Cell Carcinoma 1. Background For patients who have
More informationI have no financial interests in any product I will discuss today.
Cervical Cancer Prevention: 2012 and Beyond George F. Sawaya, MD Professor Department of Obstetrics, Gynecology and Reproductive Sciences Department of Epidemiology and Biostatistics University of California,
More informationDiploma examination. Dermatopathology: First paper. Tuesday 21 March Candidates must answer FOUR questions ONLY. Time allowed: Three hours
Dermatopathology: First paper Tuesday 21 March 2017 1. Discuss the role of fluorescent in-situ hybridization (FISH) and emerging molecular techniques in the diagnosis of cutaneous melanocytic lesions,
More informationMalignant tumors of melanocytes : Part 3. Deba P Sarma, MD., Omaha
Malignant tumors of melanocytes : Part 3 Deba P Sarma, MD., Omaha Let s go over one case of melanoma using the following worksheet. Of the various essential information that needs to be included in the
More information